SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 34 filers reported holding SORRENTO THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3 | -99.9% | 3,000 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $5,000 | -37.5% | 3,000 | 0.0% | 0.00% | -50.0% |
| Q2 2022 | $8,000 | +14.3% | 3,000 | 0.0% | 0.00% | +100.0% |
| Q1 2022 | $7,000 | -50.0% | 3,000 | 0.0% | 0.00% | -66.7% |
| Q4 2021 | $14,000 | -39.1% | 3,000 | 0.0% | 0.00% | -25.0% |
| Q3 2021 | $23,000 | -53.1% | 3,000 | -40.7% | 0.00% | -55.6% |
| Q2 2021 | $49,000 | +16.7% | 5,059 | 0.0% | 0.01% | +12.5% |
| Q1 2021 | $42,000 | -23.6% | 5,059 | -37.2% | 0.01% | -33.3% |
| Q4 2020 | $55,000 | -38.9% | 8,059 | 0.0% | 0.01% | -42.9% |
| Q3 2020 | $90,000 | +190.3% | 8,059 | +65.5% | 0.02% | +200.0% |
| Q2 2020 | $31,000 | +287.5% | 4,870 | +16.0% | 0.01% | +250.0% |
| Q1 2020 | $8,000 | -27.3% | 4,200 | +31.2% | 0.00% | -33.3% |
| Q4 2019 | $11,000 | +57.1% | 3,200 | 0.0% | 0.00% | +50.0% |
| Q3 2019 | $7,000 | – | 3,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 1,711,063 | $14,355,000 | 5.36% |
| Avoro Capital Advisors LLC | 2,151,437 | $18,051,000 | 4.69% |
| Cormorant Asset Management, LP | 2,095,334 | $17,580,000 | 2.81% |
| ACUTA CAPITAL PARTNERS, LLC | 300,000 | $2,517,000 | 1.46% |
| AlpInvest Partners B.V. | 86,540 | $726,000 | 1.43% |
| Healthcare Value Capital, LLC | 50,000 | $420,000 | 0.60% |
| Aisling Capital LLC | 353,855 | $2,969,000 | 0.52% |
| CAPITAL MANAGEMENT ASSOCIATES /NY/ | 20,000 | $168,000 | 0.26% |
| HAMILTON LANE ADVISORS LLC | 51,582 | $433,000 | 0.21% |
| Spark Investment Management LLC | 106,400 | $891,000 | 0.12% |